Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial
SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer
NCI Begins Ovarian Cancer Trial To Build Blood Samples
Aromasin Approved By FDA For ER+ Early Breast Cancer
NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk
HRT Doesn’t Raise Cancer Risk Following Oophorectomy
Obesity, Faster Weight Gain, Linked To Poor Prognosis
Study Finds Up To 12 Percent Of Specimens Misdiagnosed
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”